SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig Rogers who wrote (7610)5/1/1998 4:34:00 PM
From: VLAD  Read Replies (2) of 23519
 
Just some info for those who don't know:

First Call estimates for Q2 is -.03

Current Ratings:

Strong Buy-1 (Cruttendon Roth)
Buy-1 (Genesis Merchant)
Hold-3 (First Boston, Dain Bosworth, Pain Webber)

Pain Webber will probably issue an upgrade in the near future.

News to watch for this month:
1)Official FDA approval of new plant. Should be by May 15th.
2)Shareholder's meeting May 21st.
3)Options expiration May 15th.
4)Script numbers reported every Monday--someone call Dr. Bond and ask him for the numbers and post. I'm leaving town and won't be on line till next week.

PS scope you owe me a T-shirt. HaHa-made it right on the line.

VLAD
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News